Table 1 Details of rheumatoid arthritis (RA) and non-RA patients
From: Chemokine receptors in the rheumatoid synovium: upregulation of CXCR5
Patient (sex, age [years]) | Diagnosis/pathology | Disease duration (years) | Medication |
|---|---|---|---|
1 (male, 69) | RA | 37 | Auranofin, NSAID |
2 (female, 41) | RA | 23 | NSAID |
3 (female, 51) | RA | 10 | NSAID, analgesic |
4 (female, 79) | RA | 4 | Methotrexate, NSAID, steroid |
5 (female, 70) | RA | 8 | Penicillamine, steroid, NSAID |
6 (female, 63) | RA + secondary osteoarthritis | 39 | Methotrexate, steroid, analgesic |
7 (female, 33) | juvenile chronic arthritis | 20 | NSAID |
8 (female, 66) | RA | 38 | NSAID, analgesic |
1 (female, 50) | Articular cartilage damage | <1 | NSAID, analgesic |
2 (male, 44) | Meniscal tear | <1 | - |
3 (male, 42) | Meniscal tear and articular cartilage damage | 4 | - |
4 (male, 60) | Meniscal degeneration | <1 | - |
5 (male, 52) | Articular cartilage degeneration | 1 | - |
6 (male, 46) | Meniscal tear | <1 | - |
7 (male, 53) | Meniscal degeneration | <1 | - |
8 (male, 38) | Meniscal tear | 1 | Steroid |
9 (male, 43) | Articular cartilage degeneration | <1 | - |
1 (female, 91) | RA | <1 | Analgesic |
2 (female, 56) | RA | <1 | NSAID, steroid, methotrexate |
3 (male, 67) | RA | Â | - |
4 (male, 67) | RA | 4 | Analgesic, NSAID, methotrexate |